Bausch Health Companies (BHC) to Release Quarterly Earnings on Thursday

Bausch Health Companies (NYSE:BHC) is expected to be announcing its earnings results before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of $1.12 per share for the quarter. Bausch Health Companies has set its FY 2025 guidance at EPS.Investors interested in registering for the company’s conference call can do so using this link.

Bausch Health Companies (NYSE:BHC) last announced its quarterly earnings data on Wednesday, February 19th. The company reported $1.21 EPS for the quarter, missing the consensus estimate of $1.65 by ($0.44). Bausch Health Companies had a negative net margin of 0.48% and a negative return on equity of 577.82%. The business had revenue of $2.56 billion during the quarter, compared to analysts’ expectations of $2.51 billion. On average, analysts expect Bausch Health Companies to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Bausch Health Companies Stock Up 5.4 %

Shares of Bausch Health Companies stock opened at $7.56 on Wednesday. The stock’s 50-day simple moving average is $7.34 and its 200-day simple moving average is $7.54. Bausch Health Companies has a 52 week low of $3.96 and a 52 week high of $11.46. The company has a market capitalization of $2.78 billion, a price-to-earnings ratio of -62.95, a PEG ratio of 0.37 and a beta of 0.68.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Royal Bank of Canada decreased their target price on Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating on the stock in a research report on Thursday, January 30th. Jefferies Financial Group reiterated a “hold” rating and issued a $8.00 target price (down from $12.00) on shares of Bausch Health Companies in a research report on Thursday, February 6th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $7.42.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.